01 1Sterling Pharma Solutions Limited
01 1Fenoldopam mesylate
01 1United Kingdom
NDC Package Code : 50384-0130
Start Marketing Date : 2002-09-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (300g/300g)
Marketing Category : BULK INGREDIENT
31
PharmaCompass offers a list of Fenoldopam Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fenoldopam Mesylate manufacturer or Fenoldopam Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fenoldopam Mesylate manufacturer or Fenoldopam Mesylate supplier.
PharmaCompass also assists you with knowing the Fenoldopam Mesylate API Price utilized in the formulation of products. Fenoldopam Mesylate API Price is not always fixed or binding as the Fenoldopam Mesylate Price is obtained through a variety of data sources. The Fenoldopam Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Corlopam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Corlopam, including repackagers and relabelers. The FDA regulates Corlopam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Corlopam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Corlopam supplier is an individual or a company that provides Corlopam active pharmaceutical ingredient (API) or Corlopam finished formulations upon request. The Corlopam suppliers may include Corlopam API manufacturers, exporters, distributors and traders.
click here to find a list of Corlopam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Corlopam as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Corlopam API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Corlopam as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Corlopam and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Corlopam NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Corlopam suppliers with NDC on PharmaCompass.
We have 1 companies offering Corlopam
Get in contact with the supplier of your choice:
